Proteins Express Health

Health Outlook is using modern proteomics to better predict health events and improve health outcomes.

Laborary vial filled with blood

More than just a vial...

New technologies allow scientists to measure thousands of proteins from a vial of blood.

...powerful health insights

The Health Prediction Company

Our Mission

  • Make better predictions of health events than available options today.
  • We use advanced statistical and AI techniques to bridge the gap between today’s world of massive proteomic datasets and real-world practice.
  • Our long-term ambition is to apply such algorithms to support measures to shift the human life expectancy curve.

We leverage health prediction algorithms across healthcare ecosystem

Management

Our Leadership Team

headshot of Howard W. Sams, CEO

Howard W. Sams

Chief Executive Officer

Previously Global Head of Siemens Digital and Computational Pathology business. Global leadership roles in Roche Diagnostics over a decade. Multiple roles at Guidant/Boston Scientific, started career at Conseco. BS, Butler University & MBA from the University of Notre Dame.

headshot of Leena Das-Young, SVP, Strategy and Innovations

Leena Das-Young, PharmD

SVP, Strategy & Innovations

Led early cancer detection at Guardant Health. Prior Global Head of Pfizer Late Phase Oncology development with multiple leadership roles in commercial & development at Pfizer & Bayer. Pre-industry roles in AIDS clinical research & direct patient care in various health systems. BS & PharmD from Purdue University.

headshot of Kyu Han, SVP Longevity Markets

Kyu Han

SVP, Longevity Markets

Leads our life insurance, life settlements & financial services verticals. Previously worked in investment banking and raised capital at JPMorgan, ABN Amro and BlueCrest. BA, Harvard. MBA, Columbia Business School.

headshot of Dan Lewis, SVP Health Markets

Dan Lewis

SVP, Health Markets

Dan Lewis was COO of The MetroHealth System, a major provider in Ohio, from 2014 to 2018. From 2018 to 2021 he ran Lobesity, a biotech company, through its successful trade sale. Dan received a BA from Kent State and an MA from The University of Akron.

headshot of Michael Powell, Director, Finance

Michael Powell

Director of Finance

Oversees finance for Health Outlook. Multiple investment banking roles with increasing responsibility. Previously was Director, Healthcare Investment Banking at Cantor Fitzgerald. Previously worked at Jefferies and Merrill Lynch. BS, Brown University. MBA, Columbia Business School.

headshot of Tim Opler, PhD, Co-Founder

Tim Opler, Ph.D.

Co-Founder

Partner at Torreya, former professor and entrepreneur. Serves on boards of multiple private companies. Previously at Credit Suisse in healthcare investment banking and at FibroGen in a strategy role. Ph.D., Econ, UCLA.

headshot of Jeremy Bowser, SVP, Oerations

Jeremy Bowser

SVP, Operations

Leads our Operations division. Previously led implementation, contracting and commercial education Teams at Roche Diagnostics. Retired Navy SEAL, served 25 years in Naval Special Warfare. Awarded 4 x Bronze Star ( twice with valor) and Purple Heart. BS, University of Charleston and is an MBA candidate with University of Chicago Booth School of Business.

headshot of Jason Wang, Chief Medical Scientist

Jason Wang

Chief Medical Scientist

Director of the Center for Policy, Outcomes, and Prevention, and Professor of Pediatrics and Health Policy at Stanford University. Co-chairs the mobile health and other new technologies group at the Stanford Center for Population Health Sciences. B.S. in molecular biology from MIT, M.D. from Harvard Medical School, and Ph.D. in policy analysis from RAND.

Board of Directors

headshot of Joseph Konowiecki, Board Member

Joseph Konowiecki, J.D.

Chairman, Alignment Health

As General Counsel for PacifiCare, one of the nation's largest health organizations, he was instrumental in closing its $9.2 billion sale to United Health. He is currently Chairman of Alignment Healthcare, a rapidly growing Medicare insurer. He serves on the board of directors for Health Outlook.

headshot of Tadd Wessel, Board Member

Tadd Wessel

Managing Partner, Petrichor Healthcare Capital Management

Mr. Wessel was formerly a Managing Director at OrbiMed Advisors and Vice President at Fortress Investment Group. He sits on numerous boards of directors of life sciences companies as well as the International Centers for Precision Oncology (ICPO) Foundation. A.B. in Biology from Princeton University.

headshot of Adam Morgan, Board Member

Adam Morgan

Partner at Avego,
CIO of Velan Capital

Career spanning two decades through the healthcare and fundamental asset management. Before Avego he worked at Broadfin Capital, Iguana Healthcare and Pura Vida Investments. Previous role at Cowen and Company. BS in Chemistry from the University of Minnesota, MBA from the Carlson School of Management at the University of Minnesota.

headshot of Peter Koerte, Board Member

Peter Koerte, Ph.D.

Chief Technology & Strategy Officer, Siemens

As CTO and CSO for Siemens AG, Peter is responsible for strategy, digitization and establishment of the industrial internet of things (IoT). Peter has had multiple global management roles at Siemen Healthineers and has also worked at BCG. He received a Ph.D. in strategy and international management from WHU Otto Beisheim School of Management.

headshot of Howard W. Sams, CEO and Board Member

Howard W. Sams

Chief Executive Officer,
Health Outlook

Previously Global Head of Siemens Digital and Computational Pathology business. Global leadership roles in Roche Diagnostics over a decade. Multiple roles at Guidant/Boston Scientific, started career at Conseco. BS, Butler University & MBA from the University of Notre Dame.

headshot of Tim Opler, PhD, Co-Founder and Board Member

Tim Opler, Ph.D.

Co-Founder,
Health Outlook

Partner at Torreya, former professor and entrepreneur. Serves on boards of multiple private companies. Previously at Credit Suisse in healthcare investment banking and at FibroGen in a strategy role. Ph.D., Econ, UCLA.

headshot of John Rydzewski, Board Member

John Rydzewski

Advisor, Health Markets,
Rand Corporation

Heads the Rand Corporation Health Advisory Board. Banker at Solomon Partners. Former fund manager and long-time investment banker. Received MBA from Wharton.

Advisory Board

headshot of Andy Dannenberg, Advisory Board Member

Andy Dannenberg, M.D.

Former Professor Medicine,
Weill Cornell Medical College

Partner at Emerald Bioventures. Formerly was Professor of Medicine at Weill Cornell Medical College. Author of 200+ scientific publications. Expert on inflammation and cancer. MD Wash U., St. Louis.

headshot of Richard Ulevitch, Advisory Board Member

Richard Ulevitch, Ph.D.

Dept. Immunology,
The Scripps Research Institute

Richard Ulevitch is professor of immunology and Chairman Emeritus of the Department of Immunology at The Scripps Research Institute. His career is marked by a number of seminal scientific discoveries in the field of innate immunity. He has a strong ongoing interest in implications of proteomics for science and medicine. He received a Ph.D. in Immunology from the University of Pennsylvania.

headshot of Paul Ridker, Advisory Board Member

Paul Ridker, M.D.

Professor of Medicine,
Harvard University

Dr. Ridker is a cardiovascular epidemiologist and biomedical researcher whose research has provided proof-of-principle for the inflammation hypothesis of atherosclerosis and the first proven anti-inflammatory treatment for coronary artery disease.

headshot of David Shulkin, Advisory Board Member

David Shulkin, M.D.

Former Secretary,
Veterans Administration

Dr. Shulkin is an American physician and former U.S. Secretary of Veterans Affairs. Shulkin was also CEO of Beth Israel Medical Center and was president of Morristown Medical Center. He was the first CMO of the University of Pennsylvania Hospital.

headshot of Thomas E. Rohan, Advisory Board Member

Thomas E. Rohan, M.B.B.S., PH.D., D.H.Sc.

Professor, Department of Epidemiology & Population Health

Dr. Rohan is a cancer epidemiologist who studies the role of genetic/molecular, nutritional, and hormonal factors in the etiology and pathogenesis of a wide range of cancers. In addition to being chair of the department of epidemiology and population health, Dr. Rohan is associate director for population sciences in the Albert Einstein Cancer Center. He is on the editorial board of several journals, and is a member of several professional societies.

headshot of Mark Simon, Advisory Board Member

Mark Simon

Co-Founder and Advisor,
Torreya

Mark Simon is a partner at Torreya Partners, which he co-founded in 2007. He brings over 20 years of experience in advising biotech companies. He is active on numerous boards including that for the Alliance for Aging Research. Before Torreya, Simon in investment banking at Citigroup and Robertson Stephens. Mark received an MBA from Harvard Business School.

The Health
Prediction Company

Get in touch